IGF1R and cancer: In many cancers, IGF-1R signalling leads to activation of PI-3 K and MAPK pathways, stimulates proliferation, promotes angiogenesis and metastasis, and inhibits apoptosis (Khandwala et al, 2000; Pollak, 2000; Yu and Rohan, 2000; Wang and Sun, 2002).